Analysis

New library building the LINC between pharmaceutical industry and academia

New library building the LINC between pharmaceutical industry and academia

Closing the US pharmaceutical industry’s growing skills gap

Closing the US pharmaceutical industry’s growing skills gap

PhRMA: resetting the conversation

PhRMA: resetting the conversation

US drug imports: a recipe for disaster?

US drug imports: a recipe for disaster?

Roundtable: discussing trends in contract manufacturing

Roundtable: discussing trends in contract manufacturing

Are cheap Canadian drugs a solution to US pricing issues?

Are cheap Canadian drugs a solution to US pricing issues?

BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial

BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial

Pharma Technology Focus – Issue 59

Pharma Technology Focus – Issue 59

Crowdfunding for cancer therapy

Crowdfunding for cancer therapy

Pharmaceutical packaging: where should drug companies focus their efforts?

Pharmaceutical packaging: where should drug companies focus their efforts?

Pharma Technology Focus – Issue 57

Pharma Technology Focus – Issue 57

BlueRock Therapeutics: Ontario’s home-grown stem cell contender

BlueRock Therapeutics: Ontario’s home-grown stem cell contender

Takeda turns its focus overseas

Takeda turns its focus overseas

Is US drug manufacturing homeward bound?

Is US drug manufacturing homeward bound?

Medicines Discovery Catapult: improving collaborative drug discovery in the UK

Medicines Discovery Catapult: improving collaborative drug discovery in the UK

Therapeutic orphans: child-friendly drugs and the quest for adherence

Therapeutic orphans: child-friendly drugs and the quest for adherence

A peptide to prevent pre-diabetes

A peptide to prevent pre-diabetes

The Hive: new incubator makes a beeline for non-traditional pharma companies

The Hive: new incubator makes a beeline for non-traditional pharma companies

Tackling false trial data in China

Tackling false trial data in China

Pfizer’s big antibiotic buyout: a sign of things to come?

Pfizer’s big antibiotic buyout: a sign of things to come?

Plague, Flu and Zika: could 2017 bring vaccines for all three?

Plague, Flu and Zika: could 2017 bring vaccines for all three?